Literature DB >> 36219377

Reinventing the Penumbra - the Emerging Clockwork of a Multi-modal Mechanistic Paradigm.

Jakob Walther1,2, Elena Marie Kirsch1,2, Lina Hellwig1,2, Sarah S Schmerbeck1,2, Paul M Holloway3, Alastair M Buchan4,5, Philipp Mergenthaler6,7,8,9.   

Abstract

The concept of the ischemic penumbra was originally defined as the area around a necrotic stroke core and seen as the tissue at imminent risk of further damage. Today, the penumbra is generally considered as time-sensitive hypoperfused brain tissue with decreased oxygen and glucose availability, salvageable tissue as treated by intervention, and the potential target for neuroprotection in focal stroke. The original concept entailed electrical failure and potassium release but one short of neuronal cell death and was based on experimental stroke models, later confirmed in clinical imaging studies. However, even though the basic mechanisms have translated well, conferring brain protection, and improving neurological outcome after stroke based on the pathophysiological mechanisms in the penumbra has yet to be achieved. Recent findings shape the modern understanding of the penumbra revealing a plethora of molecular and cellular pathophysiological mechanisms. We now propose a new model of the penumbra, one which we hope will lay the foundation for future translational success. We focus on the availability of glucose, the brain's central source of energy, and bioenergetic failure as core pathophysiological concepts. We discuss the relation of mitochondrial function in different cell types to bioenergetics and apoptotic cell death mechanisms, autophagy, and neuroinflammation, to glucose metabolism in what is a dynamic ischemic penumbra.
© 2022. The Author(s).

Entities:  

Keywords:  Apoptosis; Autophagy; Cell death; Glucose metabolism; Mitochondria; Neuroinflammation; Penumbra; Stroke

Year:  2022        PMID: 36219377     DOI: 10.1007/s12975-022-01090-9

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN: 1868-4483            Impact factor:   6.800


  230 in total

Review 1.  Heterogeneity in the penumbra.

Authors:  Gregory J del Zoppo; Frank R Sharp; Wolf-Dieter Heiss; Gregory W Albers
Journal:  J Cereb Blood Flow Metab       Date:  2011-07-06       Impact factor: 6.200

2.  The cerebral ischemic penumbra.

Authors:  A M Hakim
Journal:  Can J Neurol Sci       Date:  1987-11       Impact factor: 2.104

3.  Relationship between the cortical evoked potential and local cortical blood flow following acute middle cerebral artery occlusion in the baboon.

Authors:  N M Branston; L Symon; H A Crockard; E Pasztor
Journal:  Exp Neurol       Date:  1974-11       Impact factor: 5.330

4.  Thresholds in cerebral ischemia - the ischemic penumbra.

Authors:  J Astrup; B K Siesjö; L Symon
Journal:  Stroke       Date:  1981 Nov-Dec       Impact factor: 7.914

5.  Cortical evoked potential and extracellular K+ and H+ at critical levels of brain ischemia.

Authors:  J Astrup; L Symon; N M Branston; N A Lassen
Journal:  Stroke       Date:  1977 Jan-Feb       Impact factor: 7.914

Review 6.  Pathophysiology of stroke: lessons from animal models.

Authors:  Philipp Mergenthaler; Ulrich Dirnagl; Andreas Meisel
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

Review 7.  Global Epidemiology of Stroke and Access to Acute Ischemic Stroke Interventions.

Authors:  Vasu Saini; Luis Guada; Dileep R Yavagal
Journal:  Neurology       Date:  2021-11-16       Impact factor: 9.910

8.  Experimental cerebral ischemia in mongolian gerbils. I. Light microscopic observations.

Authors:  U Ito; M Spatz; J T Walker; I Klatzo
Journal:  Acta Neuropathol       Date:  1975-08-27       Impact factor: 17.088

9.  Temporal profile of neuronal damage in a model of transient forebrain ischemia.

Authors:  W A Pulsinelli; J B Brierley; F Plum
Journal:  Ann Neurol       Date:  1982-05       Impact factor: 10.422

Review 10.  Do stroke models model stroke?

Authors:  Philipp Mergenthaler; Andreas Meisel
Journal:  Dis Model Mech       Date:  2012-11       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.